Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy - New Zealand
doi 10.2147/lctt.s6861
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Nicotinic-nAChR Signaling Mediates Drug Resistance in Lung Cancer

Journal of Cancer
Oncology
2020English

Drug Resistance in Cancer Therapy

Drug Delivery and Translational Research
Pharmaceutical Science
2011English

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Novel Drug-Resistance Mechanisms of Pemetrexed-Treated Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2016English

Functional miRNAs in Breast Cancer Drug Resistance

OncoTargets and Therapy
OncologyPharmacology
2018English

WNT Signaling and Drug Resistance in Cancer

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Lung Cancer Tumorigenicity and Drug Resistance Are Maintained Through ALDHhi CD44hi Tumor Initiating Cells

Oncotarget
Oncology
2013English

Cancer Drug Resistance: A New Perspective

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy